It is not just the statement which caught my attention but his level of confidence/ eagerness of pimavanserin's success in Alzheimer's disease psychosis.
Re-read what he wrote:
"Great to see press release that the phase 3 clinical trial of pimavanserin for treating psychosis in people with Alz Dis (following on from our phase 2 trial) has been stopped early because of CLEAR BENEFIT. Look forward to seeing the full results!! #exeterdementia"